Drug Research
Priority Review of Lynparza If Paired With Abiraterone In US
Priority consideration has been given to AstraZeneca's supplemental new drug application for Lynparza (olaparib) when used in conjunction with abiraterone, prednisone, or prednisolone to...
News
Healthcare Benefits of Using Turmeric
Itโs not surprising that turmeric has become one of the most common pantry staples and popular supplements. After all, not only does the spice...
Drug Research
Trends of Genuv Cancer Drug Show Potential For Alzheimers
Mekinist (trametinib), which has been licenced by the FDA for the treatment of melanoma, was shown in a preclinical trial to have a neuroprotective...
Drug Research
Axsome Pitches Auvelity As A Depression Med Game-Changer
It is commonly known that there are insufficient therapy choices for major depressive disorder. Then the pandemic struck, increasing the number of patients with...
News
As Vaccine Firms Prep For A Busy Season, Influenza May Hit
Flu season is just around the horizon as the summer draws to a close and fall looms. Influenza still poses a threat, and leading...
Drug Research
Gene Therapy By Bluebird Bio Costing $2.8M Given Nod By FDA
Gene therapy for blood disorders developed by Bluebird Bio has already left the nest in the US.
Zynteglo, sometimes known as betibeglogene autotemcel (beti-cel), was...
Press Releases
Achema 2022: Syntegon presents new Service Agreements
At this yearโs Achema, Syntegon will present redesigned Service Agreement packages for effective asset and maintenance management at fixed costs. The varied agreements help...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read
















